Health Blog

Tips | Recommendations | Reviews

What is mavyret treatment medicine pricing without insurance?

what is mavyret treatment medicine pricing without insurance
If you are concerned about the price of MAVYRET, you have choices. – * Cure is defined as no detectable hep C virus in the blood three months after therapy finishes. Individual outcomes might vary. As of January 2022, the advertised price, also known as the Wholesale Acquisition Cost (WAC), for one month of MAVYRET is $13,200.00.

If you have: You could pay:
$ 20
Medicaid $ 20 $20.00 or less per month, depending on state plan
Commercial Insurance (usually provided by employer) (Blue Cross Blue Shield, Aetna, etc) As little as $5 a month with MAVYRET Savings Card
Medicare: Part D $660.00-3,081.00 per month, depending on coverage phase Most Medicare patients have Standard Part D prescription coverage, which has different costs depending on deductibles and coverage gaps. An Insurance Specialist can help you understand what these costs mean to you, by calling 1-877-628-9738, Monthly out-of-pocket cost for MAVYRET may vary depending on patient’s other medication costs.
Medicare: Low-Income Subsidy (LIS) $9.85 per month starting January 1, 2022
Uninsured or having difficulty paying for your medication myAbbVie Assist provides AbbVie medicines to qualifying patients. Visit AbbVie.com/myAbbVieAssist or call 1-800-222-6885 to learn more.
Other Insurance (VA, DOD, TRICARE, others) Because coverage varies by plan, call 1-877-628-9738 to speak to an Insurance Specialist to find out how much MAVYRET will cost you.
*Important Details About Understanding Your Individual Costs: The chart above provides cost information based on what a person with the type of coverage listed may pay for a 4-week supply of MAVYRET. Your type of health or prescription insurance plan will determine exactly how much you will pay.

How long does an MAVYRET treatment last?

MAVYRET is indicated for 12 weeks in adult and pediatric liver or kidney transplant recipients 12 years or older or weighing at least 45 kg.

What is the quantity of MAVYRET?

Three tablets of MAVYRET are taken once day with meals. No injections or needles.

What is the latest Hep C treatment?

Latest Hepatitis C FDA Approvals –

Drug Type Dosage Form Company Hepatitis C Indications Patient Population
Mavyret (glecaprevir and pibrentasvir) FDA Approved 2017 glecaprevir NS3/4A protease inhibitor pibrentasvir NS5A inhibitor tablets, pellets (children 3 to less than 12 years old weighing less than 45 kg) AbbVie Inc. genotypes 1,2,3,4,5,6 adults and children 3 years of age and older
Vosevi (sofosbuvir, velpatasvir, and voxilaprevir) FDA Approved 2017 sofosbuvir nucleotide analog NS5B polymerase inhibitor velpatasvir NS5A inhibitor voxilaprevir NS3/4A protease inhibitor tablets Gilead Sciences, Inc. genotypes 1,2,3,4,5,6 adults
Epclusa (sofosbuvir and velpatasvir) FDA Approved 2016 sofosbuvir nucleotide analog NS5B polymerase inhibitor velpatasvir NS5A inhibitor tablets; oral pellets (for children less than 6 years old) Gilead Sciences, Inc. genotypes 1,2,3,4,5,6 adults and children 3 years of age and older
Zepatier (elbasvir and grazoprevir) FDA Approved 2016 elbasvir NS5A inhibitor grazoprevir NS3/4A protease inhibitor tablets Merck genotypes 1 or 4; is used with ribavirin in certain patient populations adults and children 12 years of age and older or weighing at least 66 lb (30 kg)
Harvoni (ledipasvir and sofosbuvir) FDA Approved 2014 ledipasvir NS5A inhibitor sofosbuvir nucleotide analog NS5B polymerase inhibitor tablets and oral pellets Gilead Sciences, Inc. genotypes 1, 4, 5 or 6; is used with ribavirin in certain patient populations adults and children 3 years and older
Sovaldi (sofosbuvir) FDA Approved 2013 sofosbuvir nucleotide analog NS5B polymerase inhibitor tablets and oral pellets Gilead Sciences, Inc. genotypes 1, 2, 3 or 4; must be given in combination with other antiviral medications (ribavirin; peginterferon alfa) adults (type 1-4) and children 3 years and older (type 2-3)
Discontinued Products
Viekira XR, Viekira Pak (dasabuvir, ombitasvir, paritaprevir, and ritonavir) FDA Approved 2016 (discontinued) dasabuvir non-nucleoside NS5B palm polymerase inhibitor ombitasvir NS5A inhibitor paritaprevir NS3/4A protease inhibitor ritonavir CYP3A inhibitor extended release tablets; tablets (co-packaged) AbbVie Inc. genotypes 1a or 1b adults
Daklinza (daclatasvir) FDA Approved 2015 (discontinued) daclatasvir NS5A inhibitor tablets BMS genotypes 1 or 3 adults
Technivie (ombitasvir, paritaprevir, and ritonavir) FDA Approved 2015 (discontinued) ombitasvir NS5A inhibitor paritaprevir NS3/4A protease inhibitor ritonavir CYP3A inhibitor tablets AbbVie Inc. genotype 4 adults
Olysio (simeprevir) FDA Approved 2013 (discontinued) simeprevir NS3/4A protease inhibitor capsules Janssen Pharmaceuticals, Inc. genotypes 1 or 4 adults
Incivek (telaprevir) FDA Approved 2011 (discontinued) telaprevir NS3/4A protease inhibitor tablets Vertex Pharmaceuticals Inc. genotype 1 adults
Victrelis (boceprevir) FDA Approved 2011 (discontinued) boceprevir NS3/4A protease inhibitor capsules Merck genotype 1 adults

References are available at Oral Hepatitis C Treatments: The Evolving Landscape. The prescription information for Zepatier. Dated as of 12/2021. Whitehouse Station, New Jersey, Merck Drugs@FDA. Retrieved from https://www.accessdata.fda.gov/drugsatfda docs/label/2021/208261s007lbl.pdf on February 23, 2022.

Mavyret (glecaprevir and pibrentasvir), AbbVie, North Chicago, Illinois. Retrieved from https://www.rxabbvie.com/pdf/mavyret pi.pdf on September 10, 2021. Vosevi (sofosbuvir, velpatasvir, and voxilaprevir), Gilead Sciences, Foster City, California. Dated as of 11/2019. Retrieved from https://www.gilead.com//media/Files/pdfs/medicines/liver-disease/vosevi/vosevi pi.pdf on February 11, 2021.

Epclusa (sofosbuvir and velpatasvir). Gilead Sciences, Foster City, California. Dated as of 07/2020.14 June 2021. Retrieved from https://www.gilead.com//media/Files/pdfs/medicines/liver-disease/epclusa/epclusa pi.pdf

Adblock
detector